Gary S. Gillheeney, President and CEO at Organogenesis Holdings Inc. (ORGO), sold 494,668 shares at $5.53 ($2.7M) on 2022-06-03, disclosed to the SEC on 2022-06-03.
Open-market sale of $2.7M ORGO by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.52 | 94,487 | $522K | 19.0% |
| 2 | $5.52 | 94,487 | $522K | 19.0% |
| 3 | $5.58 | 116,608 | $651K | 23.7% |
| 4 | $5.58 | 116,608 | $651K | 23.7% |
| 5 | $5.53 | 36,239 | $200K | 7.3% |
| 6 | $5.53 | 36,239 |
| $200K |
| 7.3% |
| Total | $5.55 avg | 494,668 | $2.7M | 100% |
| Filing → |
| ORGO | SELL | 2024-12-09 | $423K | — | Filing → |
| ORGO | SELL | 2022-05-31 | $2.6M | — | Filing → |
| ORGO | SELL | 2022-05-25 | $1.9M | — | Filing → |